Related Experiment Video
Updated: Apr 27, 2026
07:22
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
1.4K
An update on pediatric cutaneous drug eruptions
James E Song1, Robert Sidbury2
1Department of Dermatology, University of California, Irvine School of Medicine, 118 Med Surge I, Irvine, CA 92697.
Clinics in Dermatology
|July 15, 2014
Summary
Pediatric patients can develop diverse skin rashes from any medication. This review helps identify drug eruptions, distinguishing between mild and life-threatening reactions in children.
Area of Science:
- Dermatology
- Pediatric Medicine
- Pharmacology
Background:
- Cutaneous drug eruptions are common in clinical practice.
- Systemic medications can trigger a wide spectrum of skin reactions.
- Differentiating benign from severe drug-induced rashes is crucial for patient management.
Purpose of the Study:
- To review common and uncommon drug eruptions in pediatric patients.
- To cover the morphologic diversity of drug-induced rashes.
- To aid clinicians in assessing the severity of cutaneous drug reactions.
Main Methods:
- Literature review of drug eruptions in pediatric populations.
- Analysis of case reports and clinical studies.
- Categorization of eruptions based on morphology and clinical presentation.
Main Results:
- Drug eruptions in children present with varied morphologies.
- Reactions range from mild, self-limiting rashes to severe, life-threatening conditions.
- Identifying the causative agent is key to diagnosis and management.
Conclusions:
- Understanding the spectrum of drug eruptions is essential for pediatric dermatologists.
- Early recognition and appropriate management can prevent severe outcomes.
- This review provides a framework for diagnosing and classifying drug-induced rashes in children.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
400
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400
01:29Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
01:30Drug Toxicity: Allergic Reactions
206
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
206
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
405
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
954
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
547
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
547